aTYR PHARMA INC
ATYR· Nasdaq
ATYRaTYR PHARMA INC
Filed Mar 26, 2019 · 10-K · 85 days after period end · 0001564590-19-009381
| Metric | Q4 2018 | Q4 2017 | Q4 2016 | Q4 2015 |
|---|---|---|---|---|
| Net Income | -$6.32M | -$11.47M | -$12.57M | -$16.49M |
| EPS Diluted | -$2.92 | -$0.39 | -$0.53 | -$0.70 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
aTYR PHARMA INC · CIK 1339970 · Engraved from SEC EDGAR
ended Dec 31, 2018 · filed Mar 26, 2019 · 85 d after period end
